{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:03:02Z","timestamp":1791014582142,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.canlet.2008.04.023","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T10:02:31Z","timestamp":1212055351000},"page":"191-201","source":"Crossref","is-referenced-by-count":105,"title":["Prodrug cancer gene therapy"],"prefix":"10.1016","volume":"270","author":[{"given":"Cestmir","family":"Altaner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.04.023_bib1","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib2","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.1158\/0008-5472.CAN-06-4024","article-title":"Adipose tissue-derived mesenchymal stem cells mediated prodrug cancer gene therapy","volume":"67","author":"Kucerova","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s11060-007-9332-4","article-title":"Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines","volume":"83","author":"Birnbaum","year":"2007","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.canlet.2008.04.023_bib4","first-page":"3","article-title":"Cancer stem cells \u2013 perspectives on current status and future directions: AACR workshop on cancer stem cells","volume":"39","author":"Clarke","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib5","first-page":"435","article-title":"Cancer stem cells minireview","volume":"52","author":"Soltysova","year":"2005","journal-title":"Neoplasma"},{"key":"10.1016\/j.canlet.2008.04.023_bib6","first-page":"4735","article-title":"Gene-directed enzyme prodrug therapy with a mustard prodrug\/carboxypeptidase G2 combination","volume":"56","author":"Marais","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib7","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/0959-8049(95)00436-X","article-title":"Expression of the bacterial nitroreductase enzyme in mammalian cells renders them selectively sensitive to killing by the prodrug CB1954","volume":"31A","author":"Bridgewater","year":"1995","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2008.04.023_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0169-409X(95)00062-C","article-title":"VDEPT; an enzyme\/prodrug gene therapy approach for the treatment of metastatic colorectal cancer","volume":"17","author":"Huber","year":"1995","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.canlet.2008.04.023_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/sj.gt.3301432","article-title":"Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques","volume":"8","author":"Eaton","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib10","doi-asserted-by":"crossref","first-page":"8302","DOI":"10.1073\/pnas.91.17.8302","article-title":"Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase","volume":"91","author":"Huber","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.04.023_bib11","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.cgt.7700154","article-title":"Expression of Escherichia coli uracil phosphorihosyltransferase gene in murine colon carcinoma cells augments the antitumoral effect of 5-fluorouracil and induces protective immunity","volume":"7","author":"Kawamura","year":"2000","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2006.11.024","article-title":"Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites","volume":"251","author":"Li","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.04.023_bib13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jhep.2004.12.037","article-title":"Systemic efficacy of combined suicide\/cytokine gene therapy in a murine model of hepatocellular carcinoma","volume":"42","author":"Stefani","year":"2005","journal-title":"J. Hepatol."},{"key":"10.1016\/j.canlet.2008.04.023_bib14","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1128\/JVI.78.3.1384-1392.2004","article-title":"Multiple modifications allow high-titer production of retroviral vectors carrying heterologous regulatory elements","volume":"78","author":"Hlavaty","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canlet.2008.04.023_bib15","first-page":"2337","article-title":"High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter\u2013enhancer","volume":"62","author":"Nyati","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.gt.3302640","article-title":"Hypoxia- and radiation-activated Cre\/loxP \u2018molecular switch\u2019 vectors for gene therapy of cancer","volume":"13","author":"Greco","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.bjc.6603930","article-title":"In vitro evaluation of cancer-specific NF-kappaB-CEA enhancer\u2013promoter system for 5-fluorouracil prodrug gene therapy in colon cancer cell lines","volume":"97","author":"Guo","year":"2007","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.canlet.2008.04.023_bib18","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/sj.gt.3301549","article-title":"Chimeric PSA enhancers exhibit augmented activity in prostate cancer gene therapy vectors","volume":"8","author":"Wu","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1006\/geno.2000.6446","article-title":"A transcriptional enhancer of the prostate-specific membrane antigen gene","volume":"73","author":"Watt","year":"2001","journal-title":"Genomics"},{"key":"10.1016\/j.canlet.2008.04.023_bib20","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/S0022-5347(05)64239-5","article-title":"Adenovirus mediated prostate specific enzyme prodrug gene therapy using prostate specific antigen promoter enhanced by the Cre-loxP system","volume":"168","author":"Yoshimura","year":"2002","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2008.04.023_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1525-0016(02)00059-X","article-title":"Development of a prostate-specific promoter for gene therapy against androgen-independent prostate cancer","volume":"7","author":"Furuhata","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib22","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/sj.gt.3301972","article-title":"In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia","volume":"10","author":"Park","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/13543784.15.8.947","article-title":"Novel gene-directed enzyme prodrug therapies against prostate cancer","volume":"15","author":"Russell","year":"2006","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2008.04.023_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mam.2006.12.001","article-title":"Suicide genes for cancer therapy","volume":"28","author":"Portsmouth","year":"2007","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.canlet.2008.04.023_bib25","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1073\/pnas.74.12.5716","article-title":"Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine","volume":"74","author":"Elion","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.04.023_bib26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1566523033347426","article-title":"Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene\/Ganciclovir system: fifteen years of application","volume":"3","author":"Fillat","year":"2003","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(01)00679-6","article-title":"Cell death associated with genetic prodrug activation therapy of colorectal cancer","volume":"174","author":"Todryk","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.04.023_bib28","first-page":"495","article-title":"Suicide gene therapy with herpes simplex virus thymidine kinase and ganciclovir is enhanced with connexins to improve gap junctions and bystander effects","volume":"2","author":"Nicholas","year":"2003","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.canlet.2008.04.023_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2174\/1566523023347733","article-title":"Influence of the bystander effect on HSV-tk\/GCV gene therapy. A review","volume":"2","author":"van Dillen","year":"2002","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib30","first-page":"3989","article-title":"Bystander effect in herpes simplex virus-thymidine kinase\/ganciclovircancer gene therapy: role of gap-junctional intercellular communication","volume":"60","author":"Mesnil","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib31","first-page":"5274","article-title":"The \u201cbystander effect\u201d: tumor regression when a fraction of the tumor mass is genetically modified","volume":"53","author":"Freeman","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib32","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/hum.2005.16.1389","article-title":"Fusion of the human immunodeficiency virus type 1 tat protein transduction domain to thymidine kinase increases bystander effect and induces enhanced tumor killing in vivo","volume":"16","author":"Tasciotti","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib33","first-page":"83","article-title":"Prodrug-activated gene therapy: involvement of an immunological component in the bystander effect","volume":"3","author":"Gagandeep","year":"1996","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/(SICI)1097-0215(19970410)71:2<267::AID-IJC23>3.0.CO;2-D","article-title":"Generation of an anti-tumour immune response in a non-immunogenic tumour: HSVtk killing in vivo stimulates a mononuclear cell infiltrate and a Th1-like profile of intratumoural cytokine expression","volume":"71","author":"Vile","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2008.04.023_bib35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0360-3016(01)02754-7","article-title":"Radiosensitization of human glioma cells in vitro and in vivo with acyclovir and mutant HSV-TK75 expressed from adenovirus","volume":"52","author":"Rosenberg","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2008.04.023_bib36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.cgt.7700589","article-title":"Adenovirus-mediated gene transfer of enhanced herpes simplex virus thymidine kinase mutants improves prodrug-mediated tumor cell killing","volume":"10","author":"Wiewrodt","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib37","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/sj.gt.3301730","article-title":"Hydroxyurea significantly enhances tumor growth delay in vivo with herpes simplex virus thymidine kinase\/ganciclovir gene therapy","volume":"9","author":"Boucher","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib38","first-page":"1631","article-title":"Synergistic enhancement of herpes simplex virus thymidine kinase\/gancidovir-mediated cytotoxicity by hydroxyurea","volume":"60","author":"Boucher","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.canlet.2007.11.011","article-title":"Combination gene therapy using multidrug resistance (MDRl) gene shRNA and herpes simplex virus-thymidine kinase","volume":"261","author":"Park","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.04.023_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ymthe.2005.07.643","article-title":"In vitro and in vivo enhancement of ganciclovir-mediated bystander cytotoxicity with gemcitabine","volume":"12","author":"Boucher","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib41","doi-asserted-by":"crossref","first-page":"12873","DOI":"10.1073\/pnas.0605496103","article-title":"Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses","volume":"103","author":"Fulci","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.04.023_bib42","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/153303460500400404","article-title":"Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity","volume":"4","author":"Robson","year":"2005","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2008.04.023_bib43","first-page":"3399","article-title":"Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil","volume":"18","author":"Kuriyama","year":"1998","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib44","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.4049\/jimmunol.154.10.5302","article-title":"5-Fluorocytosine-induced eradication of murine adenocarcinomas engineered to express the cytosine deaminase suicide gene requires host immune competence and leaves an efficient memory","volume":"154","author":"Consalvo","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.canlet.2008.04.023_bib45","first-page":"1503","article-title":"Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor","volume":"54","author":"Mullen","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2407-5-51","article-title":"Adenovirus-mediated interleukin12 gene transfer combined with cytosine deaminase followed by 5-fluorocytosine treatment exerts potent antitumor activity in Renca tumor-bearing mice","volume":"5","author":"Hwang","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canlet.2008.04.023_bib47","first-page":"6649","article-title":"Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts","volume":"60","author":"Kievit","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib48","first-page":"3813","article-title":"In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase\/uracil phosphoribosyltransferase fusion gene","volume":"60","author":"Erbs","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib49","first-page":"6847","article-title":"Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene","volume":"63","author":"Ramnaraine","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib50","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/sj.gt.3301557","article-title":"In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase","volume":"8","author":"Chung-Faye","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/sj.cgt.7701098","article-title":"Modified vaccinia virus Ankara as a vector for suicide gene therapy","volume":"15","author":"Erbs","year":"2008","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib52","first-page":"4205","article-title":"Virally directed cytosine deaminase\/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts","volume":"57","author":"Hanna","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib53","first-page":"4325","article-title":"Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo","volume":"57","author":"Pederson","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib54","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/sj.cgt.7700750","article-title":"Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization","volume":"12","author":"Conrad","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib55","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/sj.gt.3301196","article-title":"Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models","volume":"7","author":"Stackhouse","year":"2000","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib56","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.ymthe.2005.03.017","article-title":"Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma","volume":"12","author":"Tai","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ymthe.2005.10.005","article-title":"Second-generation replication-competent oncolytic adenovirus armed with improved suicide genes and ADP gene demonstrates greater efficacy without increased toxicity","volume":"13","author":"Barton","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.canlet.2007.02.002","article-title":"Oncolytic viruses in cancer therapy","volume":"254","author":"V\u00e4h\u00e4-Koskela","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.04.023_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2007.10.034","article-title":"Bacterial targeted tumour therapy-dawn of a new era","volume":"259","author":"Wei","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2008.04.023_bib60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2325\/jbcs.13.27","article-title":"Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients","volume":"13","author":"Fujimori","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.canlet.2008.04.023_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.cgt.7700634","article-title":"Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients","volume":"10","author":"Nemunaitis","year":"2003","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib62","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1158\/1535-7163.MCT-07-0297","article-title":"Collaboration between hepatic and intratumoral prodrug activation in a P450 prodrug-activation gene therapy model for cancer treatment","volume":"6","author":"Ma","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib63","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(00)04749-8","article-title":"Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma","volume":"357","author":"Lohr","year":"2001","journal-title":"Lancet"},{"issue":"Suppl.","key":"10.1016\/j.canlet.2008.04.023_bib64","first-page":"1584","article-title":"Treatment of inoperable pancreatic carcinoma using a cell-based local chemotherapy: results of a phase I\/II clinical trial","volume":"38","author":"Salmons","year":"2003","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.canlet.2008.04.023_bib65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1081\/LPR-64953","article-title":"Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids","volume":"15","author":"Kostarelos","year":"2005","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib66","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.4161\/cbt.5.12.3379","article-title":"Tissue specific expression of suicide genes delivered by nanoparticles inhibits gastric carcinoma growth","volume":"12","author":"Liu","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib67","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1128\/MCB.10.8.4239","article-title":"Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection","volume":"10","author":"Miller","year":"1990","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2008.04.023_bib68","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/mt.sj.6300122","article-title":"Engineered human tmpk\/AZT as a novel enzyme\/prodrug axis for suicide gene therapy","volume":"5","author":"Sato","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib69","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.2741\/2910","article-title":"Replication-competent retrovirus vectors for cancer gene therapy","volume":"13","author":"Chien-Kup","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2008.04.023_bib70","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.04.023_bib71","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.2741\/2872","article-title":"Cancer gene therapy using adeno-associated virus vectors","volume":"13","author":"Park","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2008.04.023_bib72","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2741\/2823","article-title":"Oncolytic virus therapy using genetically engineered herpes simplex viruses","volume":"13","author":"Todo","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2008.04.023_bib73","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.04.023_bib74","first-page":"3603","article-title":"Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors","volume":"62","author":"Studeny","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib75","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/jnci\/djh299","article-title":"Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents","volume":"96","author":"Studeny","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2008.04.023_bib76","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1158\/0008-5472.CAN-04-1874","article-title":"Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas","volume":"65","author":"Nakamizo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib77","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.20051921","article-title":"Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi\u2019s sarcoma","volume":"203","author":"Khakoo","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2008.04.023_bib78","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1158\/1078-0432.CCR-05-0876","article-title":"Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging","volume":"11","author":"Hung","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib79","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","article-title":"Bone marrow cells in the \u2018pre-metastatic niche\u2019: within bone and beyond","volume":"25","author":"Kaplan","year":"2006","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2008.04.023_bib80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1349-7006.2005.00032.x","article-title":"Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy","volume":"96","author":"Hamada","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2008.04.023_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/10430340360464714","article-title":"Multilineage cells from adipose tissue as gene delivery vehicles","volume":"14","author":"Morizono","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib82","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1517\/14712598.5.12.1571","article-title":"Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases","volume":"12","author":"Reiser","year":"2005","journal-title":"Rev., Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib83","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.canlet.2008.04.023_bib84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1158\/1535-7163.MCT-05-0334","article-title":"Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses","volume":"5","author":"Komarova","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10549-006-9449-8","article-title":"Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma","volume":"105","author":"Stoff-Khalili","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.canlet.2008.04.023_bib86","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.gt.3302276","article-title":"Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model","volume":"11","author":"Nakamura","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/104303404323142042","article-title":"Marrow stromal cells for interleukin-2 delivery in cancer immunotherapy","volume":"15","author":"Stagg","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib88","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.canlet.2008.04.023_bib89","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.V98.9.2615","article-title":"Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells","volume":"98","author":"Reyes","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.04.023_bib90","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1242\/jcs.00369","article-title":"Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow","volume":"116","author":"Gronthos","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2008.04.023_bib91","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2302\/kjm.54.132","article-title":"Multipotential differentiation of adipose tissue-derived stem cells","volume":"54","author":"Strem","year":"2005","journal-title":"Keio J. Med."},{"key":"10.1016\/j.canlet.2008.04.023_bib92","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.exphem.2005.07.003","article-title":"Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood","volume":"33","author":"Wagner","year":"2005","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.canlet.2008.04.023_bib93","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2008.04.023_bib94","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1634\/stemcells.2006-0589","article-title":"Concise review: adipose tissue-derived stromal cells \u2013 basic and clinical implications for novel cell-based therapies","volume":"25","author":"Schaffler","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2008.04.023_bib95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.moh.0000245697.54887.6f","article-title":"Mesenchymal stromal cells","volume":"13","author":"Keating","year":"2006","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.canlet.2008.04.023_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.critrevonc.2007.09.004","article-title":"Apoptosis in normal and cancer stem cells","volume":"66","author":"Iannolo","year":"2008","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.canlet.2008.04.023_bib97","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/scd.2007.0006","article-title":"Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma","volume":"16","author":"Kang","year":"2007","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.canlet.2008.04.023_bib98","first-page":"9","article-title":"Potential identity of multi-potential cancer stem-like subpopulation after radiation of cultured brain glioma","volume":"30","author":"Kang","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.canlet.2008.04.023_bib99","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-4598-5-67","article-title":"Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma","volume":"5","author":"Liu","year":"2006","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2008.04.023_bib100","doi-asserted-by":"crossref","first-page":"5550","DOI":"10.1158\/1078-0432.CCR-05-2508","article-title":"Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression","volume":"12","author":"Kim","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"e23","key":"10.1016\/j.canlet.2008.04.023_bib101","first-page":"1","article-title":"Development of a tumor-selective approach to treat metastatic cancer","volume":"1","author":"Aboody","year":"2006","journal-title":"PLoS ONE"},{"key":"10.1016\/j.canlet.2008.04.023_bib102","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1158\/0008-5472.CAN-06-3607","article-title":"Tumor-targeted enzyme\/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma","volume":"67","author":"Danks","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.04.023_bib103","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1535-6108(04)00116-3","article-title":"Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery","volume":"5","author":"Wei","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2008.04.023_bib104","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1215\/15228517-2005-012","article-title":"Targeting of melanoma brain metastases using engineered neural stem\/progenitor cells","volume":"8","author":"Aboody","year":"2006","journal-title":"Neuro-oncology"},{"key":"10.1016\/j.canlet.2008.04.023_bib105","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1634\/stemcells.2007-0758","article-title":"Mesenchymal Stem Cells Effectively Deliver an Oncolytic Adenovirus to Intracranial Glioma","volume":"26","author":"Sonabend","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.canlet.2008.04.023_bib106","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbrc.2004.12.164","article-title":"Migratory neural stem cells for improved thymidine kinase-based gene therapy of malignant gliomas","volume":"328","author":"Uhl","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2008.04.023_bib107","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nature05349","article-title":"Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells","volume":"444","author":"Piccirillo","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.04.023_bib108","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1172\/JCI15153","article-title":"Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4","volume":"110","author":"Peng","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.canlet.2008.04.023_bib109","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/2789_2007_044","article-title":"Bone morphogenetic proteins regulate tumorigenicity in human glioblastoma stem cells","volume":"5","author":"Piccirillo","year":"2006","journal-title":"Ernst Schering Found Symp. Proc."},{"key":"10.1016\/j.canlet.2008.04.023_bib110","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.cgt.7701079","article-title":"Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells","volume":"11","author":"Kanehira","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib111","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/sj.cgt.7701077","article-title":"Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors","volume":"10","author":"Rachakatla","year":"2007","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2008.04.023_bib112","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/sj.cgt.7700848","article-title":"Development of a gene therapy based bone marrow purging system for leukemias","volume":"11","author":"Huang","year":"2005","journal-title":"Cancer Gene Ther."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508003339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508003339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T15:01:36Z","timestamp":1684422096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508003339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":112,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0304383508003339"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.04.023","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}